Apollo Global in talks to acquire J&J's orthopedics business, Bloomberg reports

Sept 11 (Reuters) - Apollo Global Management is in discussions to buy Johnson & Johnson's orthopedics business, a transaction that could value the unit at roughly $20 billion, Bloomberg News reported on Friday, citing sources.

Bloomberg News said a number of private equity firms are interested in potentially acquiring the unit, and that a deal could be completed within weeks.

Reuters was not immediately able to verify the report. Apollo Global Management and Johnson & Johnson did not immediately respond to Reuters requests for comment.

Last year, J&J said it planned to spin off its orthopedics unit, known as DePuy Synthes, into a standalone company within 18 to 24 months, as it sharpens its focus on higher-growth healthcare segments.

J&J's orthopedics unit produces hip, knee and shoulder implants, surgical instruments and other products, and generated $9.3 billion in sales in 2025.